MENU
MGNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

MacroGenics (MGNX) Earnings Date & Reports

Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

MGNX is expected to report earnings to -64 cents per share on August 12

MacroGenics MGNX Stock Earnings Reports
Q2'25
Est.
$-0.65
Q1'25
Est.
$-0.65
Q4'24
Beat
by $0.16
Q3'24
Beat
by $0.69
Q2'24
Missed
by $0.23
The last earnings report on May 13 showed earnings per share of -64 cents, meeting the estimate of -64 cents. With 257.66K shares outstanding, the current market capitalization sits at 91.48M.
View a ticker or compare two or three
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in the discovery and development of monoclonal antibody-based therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9704 Medical Center Drive
Phone
+1 301 251-5172
Employees
339
Web
https://www.macrogenics.com